{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:43:38Z","timestamp":1761896618944,"version":"3.44.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.cellimm.2017.10.010","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T03:19:12Z","timestamp":1509074352000},"page":"33-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Cyclosporin A indirectly attenuates activation of group 2 innate lymphoid cells in papain-induced lung inflammation"],"prefix":"10.1016","volume":"323","author":[{"given":"Fujimi","family":"Kudo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Ikutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Iseki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Takaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2017.10.010_b0005","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.autrev.2016.07.014","article-title":"Critical review of the current recommendations for the treatment of systemic inflammatory rheumatic diseases during pregnancy and lactation","volume":"15","author":"Levy","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cellimm.2017.10.010_b0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.critrevonc.2005.03.012","article-title":"Immunosuppressive agents in solid organ transplantation: mechanisms of action and therapeutic efficacy","volume":"56","author":"Taylor","year":"2005","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.cellimm.2017.10.010_b0015","article-title":"The use of cyclosporine a in rheumatology: a 2016 comprehensive review","author":"Chighizola","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.cellimm.2017.10.010_b0020","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nri1632","article-title":"NFAT proteins: key regulators of T-cell development and function","volume":"5","author":"Macian","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2017.10.010_b0025","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1182\/blood-2012-02-404475","article-title":"NFAT control of innate immunity","volume":"120","author":"Fric","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2017.10.010_b0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/intimm\/dxv050","article-title":"Group 2 innate lymphoid cells in disease","volume":"28","author":"Halim","year":"2016","journal-title":"Int. Immunol."},{"key":"10.1016\/j.cellimm.2017.10.010_b0035","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.coi.2015.02.001","article-title":"Epithelial cytokines and pulmonary allergic inflammation","volume":"34","author":"Lloyd","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cellimm.2017.10.010_b0040","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nri3831","article-title":"Type 2 cytokines: mechanisms and therapeutic strategies","volume":"15","author":"Wynn","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2017.10.010_b0045","doi-asserted-by":"crossref","unstructured":"D.J. Cousins, J. McDonald, T.H. Lee, Therapeutic approaches for control of transcription factors in allergic disease, J. Allergy Clin. Immunol., 121 (2008) 803\u2013809; quiz 810-801.","DOI":"10.1016\/j.jaci.2008.02.008"},{"key":"10.1016\/j.cellimm.2017.10.010_b0050","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1378\/chest.123.4.1254","article-title":"Alternate treatments in asthma","volume":"123","author":"Niven","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.cellimm.2017.10.010_b0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1067\/mai.2001.115758","article-title":"Alternative agents in asthma","volume":"108","author":"Frew","year":"2001","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellimm.2017.10.010_b0060","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1398-9995.1997.tb00181.x","article-title":"Effects of rapamycin, cyclosporin A, and dexamethasone on interleukin 5-induced eosinophil degranulation and prolonged survival","volume":"52","author":"Meng","year":"1997","journal-title":"Allergy"},{"key":"10.1016\/j.cellimm.2017.10.010_b0065","doi-asserted-by":"crossref","first-page":"16063","DOI":"10.1074\/jbc.M110.213389","article-title":"CCAAT\/enhancer-binding protein alpha (C\/EBPalpha) is critical for interleukin-4 expression in response to FcepsilonRI receptor cross-linking","volume":"286","author":"Qi","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2017.10.010_b0070","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/ni.2617","article-title":"TH2, allergy and group 2 innate lymphoid cells","volume":"14","author":"Licona-Limon","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2017.10.010_b0075","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.immuni.2011.12.020","article-title":"Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation","volume":"36","author":"Halim","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2017.10.010_b0080","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.immuni.2014.06.016","article-title":"MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion","volume":"41","author":"Oliphant","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2017.10.010_b0085","doi-asserted-by":"crossref","first-page":"18581","DOI":"10.1073\/pnas.1003059107","article-title":"IL-33 is a crucial amplifier of innate rather than acquired immunity","volume":"107","author":"Oboki","year":"2010","journal-title":"Proc. Natl. Acad. Sci USA"},{"key":"10.1016\/j.cellimm.2017.10.010_b0090","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.immuni.2015.02.007","article-title":"ICOS:ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity","volume":"42","author":"Maazi","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2017.10.010_b0095","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1002\/eji.201545635","article-title":"ICOS regulates the pool of group 2 innate lymphoid cells under homeostatic and inflammatory conditions in mice","volume":"45","author":"Paclik","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cellimm.2017.10.010_b0100","article-title":"Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator-inducible T-cell costimulator ligand","author":"Rigas","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellimm.2017.10.010_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2015.05.019","article-title":"Interleukin-33 and Interferon-gamma Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation","author":"Molofsky","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2017.10.010_b0110","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4049\/jimmunol.1101270","article-title":"Identification of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumor immunity","volume":"188","author":"Ikutani","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2017.10.010_b0115","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1084\/jem.20030298","article-title":"Blockade of inflammation and airway hyperresponsiveness in immune-sensitized mice by dominant-negative phosphoinositide 3-kinase-TAT","volume":"198","author":"Myou","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2017.10.010_b0120","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.coi.2008.04.001","article-title":"IL-5 and eosinophilia","volume":"20","author":"Takatsu","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cellimm.2017.10.010_b0125","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1073\/pnas.89.9.3686","article-title":"Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A","volume":"89","author":"Fruman","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellimm.2017.10.010_b0130","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1183\/09031936.00030711","article-title":"P.P.S.A.i.C.I. group, Pharmacological treatment of severe, therapy-resistant asthma in children: what can we learn from where?","volume":"38","author":"Bush","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cellimm.2017.10.010_b0135","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.biopha.2009.10.003","article-title":"Therapeutic targets for persistent airway inflammation in refractory asthma","volume":"64","author":"Murphy","year":"2010","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cellimm.2017.10.010_b0140","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1164\/ajrccm.162.4.9911117","article-title":"Attenuation of the allergen-induced late asthmatic reaction by cyclosporin A is associated with inhibition of bronchial eosinophils, interleukin-5, granulocyte macrophage colony-stimulating factor, and eotaxin","volume":"162","author":"Khan","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cellimm.2017.10.010_b0145","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/thx.52.5.447","article-title":"Effect of cyclosporin A on the allergen-induced late asthmatic reaction","volume":"52","author":"Sihra","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/j.cellimm.2017.10.010_b0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/imm.12537","article-title":"Interferon-gamma constrains cytokine production of group 2 innate lymphoid cells","volume":"147","author":"Kudo","year":"2016","journal-title":"Immunology"},{"key":"10.1016\/j.cellimm.2017.10.010_b0155","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.immuni.2014.09.006","article-title":"Innate lymphoid cells in inflammation and immunity","volume":"41","author":"McKenzie","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2017.10.010_b0160","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaci.2013.03.048","article-title":"Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production","volume":"132","author":"Doherty","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellimm.2017.10.010_b0165","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jaci.2013.10.056","article-title":"Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells","volume":"133","author":"Xue","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellimm.2017.10.010_b0170","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/mi.2016.4","article-title":"IL-4-producing ILC2s are required for the differentiation of TH2 cells following Heligmosomoides polygyrus infection","volume":"9","author":"Pelly","year":"2016","journal-title":"Mucosal. Immunol."},{"key":"10.1016\/j.cellimm.2017.10.010_b0175","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1084\/jem.20161274","article-title":"Leukotrienes provide an NFAT-dependent signal that synergizes with IL-33 to activate ILC2s","volume":"214","author":"von Moltke","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2017.10.010_b0180","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1182\/blood-2006-01-0329","article-title":"Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production","volume":"108","author":"Zeiser","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2017.10.010_b0185","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nri1435","article-title":"Tolerance, not immunity, crucially depends on IL-2","volume":"4","author":"Malek","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cellimm.2017.10.010_b0190","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/ni.3540","article-title":"An essential role for the IL-2 receptor in Treg cell function","volume":"17","author":"Chinen","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2017.10.010_b0195","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2017.10.010_b0200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.immuni.2015.06.021","article-title":"An interleukin-33-mast cell-interleukin-2 axis suppresses papain-induced allergic inflammation by promoting regulatory T cell numbers","volume":"43","author":"Morita","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2017.10.010_b0205","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1172\/JCI39717","article-title":"Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice","volume":"119","author":"Bedoret","year":"2009","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.cellimm.2017.10.010_b0210","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/intimm\/dxw012","article-title":"IL-10-producing lung interstitial macrophages prevent neutrophilic asthma","volume":"28","author":"Kawano","year":"2016","journal-title":"Int. Immunol."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874917301880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874917301880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:56:00Z","timestamp":1757804160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874917301880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":42,"alternative-id":["S0008874917301880"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2017.10.010","relation":{},"ISSN":["0008-8749"],"issn-type":[{"type":"print","value":"0008-8749"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclosporin A indirectly attenuates activation of group 2 innate lymphoid cells in papain-induced lung inflammation","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2017.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}